Investigation of the role of Neuromedin S, a newly identified powerful regulator of food intake. (360G-Wellcome-079527_Z_06_Z)
Neuromedin S (NMS) is a newly identified powerful regulator of food intake. I will define the role of NMS in the control of appetite and the development of obesity. My key research goals are to: Determine the distribution of NMS and its response to changes in energy intake. Investigate the effects of CNS injection of NMS on food intake. Investigate the effects of NMS on known hypothalamic regulators of appetite. Examine the effects of NMS on long-term weight regulation using adeno-associated virus mediated gene transfer. These experiments will help to determine the importance of NMS in the hypothalamic regulation of food intake.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
| Amount Awarded | 236661 |
| Applicant Surname | Jayasena |
| Approval Committee | Physiological Sciences Funding Committee |
| Award Date | 2006-07-12T00:00:00+00:00 |
| Financial Year | 2005/06 |
| Grant Programme: Title | Research Training Fellowship |
| Internal ID | 079527/Z/06/Z |
| Lead Applicant | Dr Channa Jayasena |
| Partnership Value | 236661 |
| Planned Dates: End Date | 2009-11-30T00:00:00+00:00 |
| Planned Dates: Start Date | 2006-12-01T00:00:00+00:00 |
| Recipient Org: Country | United Kingdom |
| Region | Greater London |
| Sponsor(s) | Prof Sir Stephen Bloom |